Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Alma Media issues a profit warning — the company does not issue a new guidance due to the uncertain market situation

Alma Media Corporation                                          Inside information 25 March 2020 at 1.30 p.m. ALMA MEDIA ISSUES A PROFIT WARNING — THE COMPANY DOES NOT ISSUE A NEW GUIDANCE DUE TO THE UNCERTAIN MARKET SITUATION Alma Media changes the outlook statement for 2020 due to the estimated impact of COVID-19. The guidance issued previously, on 14 February 2020, is no longer valid under the changed circumstances. Due to the exceptional change in the operating environment related to the coronavirus epidemic and the resulting increase in uncertainty, Alma Media does not issue a

Precautionary measures affecting Episurf’s Annual General Meeting as a result of the current coronavirus outbreak

Episurf Medical AB (publ) (“Episurf” or the “Company”) has taken the decision to instigate precautionary measures for the upcoming Annual General Meeting to be held at 17.30 CET on 2 April 2020 at the company’s office at Karlavägen 60 in Stockholm, as a result of the current coronavirus outbreak.In order to reduce the risk of spreading the virus and to safeguard the well-being of shareholders and Episurf’s personnel, a number of precautionary measures have been introduced: · The premises will open at 17.20 CET. · The meeting agenda will be addressed by the Chairman of the meeting

Wärtsilä advances future fuel capabilities with first ammonia tests

Wärtsilä Corporation, Trade press release, 25 March 2020 at 1 pm EETThe technology group Wärtsilä has initiated combustion trials using ammonia. The research will help the company to prepare for the use of ammonia as a fuel that can contribute to reducing both the shipping’s and energy sectors’ greenhouse gas emissions. As part of the tests, ammonia was injected into a combustion research unit to better understand its properties. Based on initial results, the tests will be continued on both dual-fuel and spark-ignited gas engines. These will be followed by field tests in collaboration

Update on Elos Medtech's assessment of COVID-19

The spread of the virus COVID-19 has evolved to become a global concern, with significant impact on the whole society since Elos Medtech published Year-end Report February 18[th]. Elos Medtech assesses, based on the current situation and information, that there is a significant risk that the outbreak of COVID-19 will have a financial impact on the company during the first half of the year, as the company anticipates disruptions in demand. The impact on the company is mainly due to changing customer needs based on the healthcare re-priorities in this emergency. As the development is

Nomination Committee proposes keeping fees unchanged

Owing to the prevailing uncertainty in society caused by Covid-19, SSAB’s Nomination Committee is now to propose that the Board of Directors and committee fees remain unchanged, which is a change from the current proposal.Owing to the prevailing uncertainty in society caused by Covid-19 and its effects on industrial production and on the economy in general, the Nomination Committee proposes that its current proposal to increase the Board fees and compensation paid for committee work to be submitted for the resolution of the Annual General Meeting on April 1, 2020 (point 9 on the AGM agenda),

Pre-recorded statement from president and CEO

Pre-recorded statement (in Swedish) by President and CEO Henrik Perbeck for Beijer Alma’s Annual General Meeting March 25, 2020.Extract from President and CEO Henrik Perbeck’s statement at the Annual General Meeting. “Looking at the economic situation in general, the slowdown at the end of last year also marked the early part of 2020. Added to this is the impact that the coronavirus outbreak has had on countries and markets across the globe. This has also affected Beijer Alma, primarily our operations in China, where production was shut down for a couple of weeks. The corona pandemic did

Impact of covid-19 on Lindab

The coronavirus (covid-19) and the extensive countermeasures implemented by local authorities in Europe will have a financial impact on the Lindab Group. The ventilation company Lindab has the construction industry as its primary target group. Lindab's sales is concentrated to Europe with less than two percent of sales outside Europe. Sales is primarily affected by the activity in European construction projects, with emphasis on the countries in Northern Europe. Lindab's assessment is that revenue in the first quarter will only be affected to a lesser extent by covid-19. Impact during

BioStock: Follicum comments on patent notice for diabetes candidate

Follicum’s diabetes project took a big leap forward last Friday with a preliminary patent approval from the European Patent Office regarding the company’s diabetes peptides. BioStock contacted CEO Jan Alenfall to find out more about the project, the patent approval, and how the company intends to position its candidate in the extensive range of diabetes treatments.Read the interview with Jan Alenfall at biostock.se: https://www.biostock.se/en/follicum-comments-on-patent-notice-for-diabetes-candidate/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.

SCO-101 works in synergy with the chemotherapy drug docetaxel in drug resistant cancer cells

Scandion Oncology A/S (“Scandion Oncology”) has published that combining SCO-101 and the chemotherapy drug docetaxel, which is used in the treatment of several types of cancer, results in synergy. Based on modelling of preclinical data with docetaxel resistant cancer cells, Scandion Oncology has published that SCO-101 significantly increases the potency of docetaxel (docetaxel belongs to the group of taxane chemotherapy). Furthermore, the results provided key information regarding promising dose ratios and dose levels for future clinical studies when using  the combination of SCO-101 and

Coronavirus: deadlines for patents and utility models

In patents and utility models, there are various deadlines that have to be met. We understand that the coronavirus causes difficulties for our customers and therefore want to support applicants in all ways permitted by law. Below you will find more instructions on the deadlines.The deadlines for responding to an office action or for filing statements are set out in our Patent Regulations and Utility Model Regulations. We can, at the request of the applicant, extend the deadline for special reasons. If you cannot meet the deadline because of the coronavirus, we consider it a special reason.

Coronavirus: deadlines for trademarks and designs

We understand that the coronavirus causes difficulties for customers and therefore want to support applicants in all ways permitted by law.   Below you will find more instructions on the deadlines.Trademarks   The deadlines for filing material or statements, or for correcting deficiencies, are set out in the Finnish Trademarks Act. Therefore, we cannot change the deadlines. We will take into account the exceptional situation caused by the coronavirus when we consider deadline extensions. We extend deadlines easier if the customer cannot act by the deadline due to the

Securitas publishes Annual and Sustainability Report for 2019

The Annual and Sustainability Report for Securitas AB for the financial year 2019 is now available.The Annual and Sustainability Report 2019 can be read and downloaded at Securitas website: https://www.securitas.com/investors/financial-reports/annual-reports/ The printed version of the Annual and Sustainability Report 2019 can as of April 16 be ordered from Securitas ordering service on the website: www.securitas.com/investors/order-and-subscribe/order-printed-material/ There is also a digital and interactive brief version of the Annual and Sustainability Report available here: https:/

Notice to attend the annual general meeting of PowerCell Sweden AB

The shareholders of Powercell Sweden AB (publ), company registration no. 556759-8353, are hereby given notice to attend the Annual General Meeting to be held on Friday, April 24, 2020 at 3:00 pm in Palmstedtsalen, Chalmers Conference Center, Chalmersplatsen 1, in Gothenburg. Registration for the Annual General Meeting will commence at 2:30 pm. The annual report for 2019 will be published on the company’s website on Friday, March 27. Due to the continued spread of the Coronavirus this year, as precautionary measure, we will not offer refreshments and will not mingle in connection with the

AVTECH provides a business update regarding COVID-19

AVTECH's management hereby wishes to provide the following update due to the ongoing global coronavirus (COVID-19) outbreak.The 2020 fiscal year was expected to be a positive year for AVTECH with several new customers as well as expanded collaboration with existing customers. This picture has now changed drastically with the global spread of the corona virus and the resulting reduced demand for air travel.Today we have a portfolio of products that are of interest to airlines in times of environmental concerns and cost savings. For this year the portfolio has been strengthened with a

Compression springs made of tool steel for high temperature applications

Innovative and progressive research and development is part of our DNA. Spring specialists in Sweden have recently made prototypes and tests of springs in a new, cost effective material that can withstand high temperatures. Test results are very positive.One of the requests of firm compression springs for high temperature applications origins from the Lesjöfors sales office in the Netherlands, where the customer wanted to replace disc springs  with compression springs 

The Nomination Committee proposes unchanged Board remuneration -adjusted version

Due to the situation with the corona pandemic, XVIVO Perfusion's Nomination Committee, and the shareholders who have appointed the members in the Nomination Committee, has decided to withdraw the proposal that XVIVO Perfusion's Annual General Meeting on March 31, 2020 approves an increase in Board remuneration (item 12 on the agenda). Instead, the Nomination Committee, and the shareholders who have appointed the members in the Nomination Committee, proposes unchanged Board remuneration compared to 2019. The Nomination Committee's other proposals for the Annual General Meeting remain

The Nomination Committee proposes unchanged Board remuneration

Due to the situation with the corona pandemic, XVIVO Perfusion's Nomination Committee has decided to withdraw the proposal that XVIVO Perfusion's Annual General Meeting on March 31, 2020 approves an increase in Board remuneration (item 12 on the agenda). Instead, the Nomination Committee proposes unchanged Board remuneration compared to 2019. The Nomination Committee's other proposals for the Annual General Meeting remain unchanged.

Polygiene: Partner places order for 55,000 sets of scrubs

An initial order of scrubs will be treated with Polygiene biostatic stays fresh technology, that is active against both bacteria and virus.*Production has resumed this week for the sportswear producer O’Neills of Northern Ireland. They received an enquiry from the health trust as there was a severe shortage of scrubs in the area, and the entire arrangement for the scrubs came together over the weekend.”The anti-bacterial Polygiene finish used by O’Neills for its sportswear had proved ideal for surgical scrubs” says Managing Director of O’Neills, Kieran Kennedy. “I think there will be a

Sharps Bedrooms Ltd follows government guidelines and temporarily ceases trading during Covid-19 outbreak

As of 24[th] March 2020, following recent UK Government recommendations with respect to the Covid-19 outbreak, SB HOLDCO PLC’s trading company, Sharps Bedrooms Limited, has temporarily ceased trading. The situation in the UK is fluid and monitored on an ongoing basis by the management team with the intention of resuming trading as soon as practically possible. Management considers the company’s liquidity position to be strong and expects to make the upcoming quarterly interest payment as scheduled. Further communication will follow as the situation develops.

Update regarding the impact from COVID-19

The outbreak of the COVID-19 means that the general global situation has changed considerably and is having a negative impact on the MQ Group. The initial impact on the Group from the COVID-19 primarily involved minor delays in the supply chain from Asia, but subsequently after several weeks it began having a significant impact on consumer behaviour in Sweden. The impact of the COVID-19 on the market is naturally something we still cannot fully analyse, but this, in combination with macroeconomic uncertainty and falling stock markets across the world, has substantially reduced the numbers

Precautionary measures at Pandox Aktiebolag (publ) AGM 3 April 2020 and new board fee proposal

Due to the risk of spreading the coronavirus Pandox has decided to undertake precautionary measures at the AGM 3 April 2020. Pandox has also been informed of the nomination committee’s decision to withdraw its previous proposal regarding an increase of fees for the board of directors, and instead propose an unchanged fee level. The AGM is planned to be held as earlier communicated – at Hilton Stockholm Slussen, Guldgränd 8 in Stockholm, 3 April at 10:00 CEST – but with precautionary measures: · The meeting is held in a larger room · No food or drinks will be offered · The

There are no items matching the current filter
There are no more items matching the current filter
Back to top